Filed: 2/14/2023ACC: 0001104659-23-022010
📋 What this filing means
VENROCK ADVISER, LLC filed this quarterly 13F‑HR report disclosing 29 equity positions with a total reported market value of $622.86M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
29
Positions
$622.86M
Total AUM (reported)
72.50M
Total Shares
Allocation by class
COM$506.45M81.3%
ORDINARY SHARES$34.19M5.5%
SPONSORED ADR$29.26M4.7%
COM NEW$28.94M4.6%
ORD SHS$16.17M2.6%
SPONSORED ADS$7.86M1.3%
Portfolio Concentration
Top 3$202.48M32.5%
4–10$224.83M36.1%
11–25$186.60M30.0%
Rest$8.95M1.4%
Top 3 weight
32.5%
Top 10 weight
68.6%
Voting Authority Distribution
Total shares with voting rights: 72.50M
Sole
Full voting authority
72.50M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole29
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings29
Rows:
VIRIDIAN THERAPEUTICS INC
SOLEShares2.70M
TypeSH
Market value$78.86M
12.66%
Sole
2.70M
Shared
0.00
None
0.00
ACLARIS THERAPEUTICS INC
SOLEShares4.56M
TypeSH
Market value$71.88M
11.54%
Sole
4.56M
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC
SOLEShares670.72K
TypeSH
Market value$51.73M
8.31%
Sole
670.72K
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares4.04M
TypeSH
Market value$46.68M
7.49%
Sole
4.04M
Shared
0.00
None
0.00
TERNS PHARMACEUTICALS INC
SOLEShares3.71M
TypeSH
Market value$37.75M
6.06%
Sole
3.71M
Shared
0.00
None
0.00
GH RESEARCH PLC
SOLEShares3.52M
TypeSH
Market value$34.19M
5.49%
Sole
3.52M
Shared
0.00
None
0.00
CELCUITY INC
SOLEShares2.11M
TypeSH
Market value$29.50M
4.74%
Sole
2.11M
Shared
0.00
None
0.00
DBV TECHNOLOGIES S A
SOLEShares9.30M
TypeSH
Market value$29.26M
4.70%
Sole
9.30M
Shared
0.00
None
0.00
DICE THERAPEUTICS INC
SOLEShares819K
TypeSH
Market value$25.55M
4.10%
Sole
819K
Shared
0.00
None
0.00
AEROVATE THERAPEUTICS INC
SOLEShares747.87K
TypeSH
Market value$21.91M
3.52%
Sole
747.87K
Shared
0.00
None
0.00
PLIANT THERAPEUTICS INC
SOLEShares1.08M
TypeSH
Market value$20.88M
3.35%
Sole
1.08M
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares2.92M
TypeSH
Market value$19.72M
3.17%
Sole
2.92M
Shared
0.00
None
0.00
NOVAVAX INC
SOLEShares1.88M
TypeSH
Market value$19.33M
3.10%
Sole
1.88M
Shared
0.00
None
0.00
MERUS N V
SOLEShares1.23M
TypeSH
Market value$18.97M
3.05%
Sole
1.23M
Shared
0.00
None
0.00
CABALETTA BIO INC
SOLEShares1.90M
TypeSH
Market value$17.53M
2.81%
Sole
1.90M
Shared
0.00
None
0.00
ANNEXON INC
SOLEShares3.22M
TypeSH
Market value$16.65M
2.67%
Sole
3.22M
Shared
0.00
None
0.00
VECTIVBIO HLDG AG
SOLEShares1.87M
TypeSH
Market value$16.17M
2.60%
Sole
1.87M
Shared
0.00
None
0.00
PROVENTION BIO INC
SOLEShares1.12M
TypeSH
Market value$11.82M
1.90%
Sole
1.12M
Shared
0.00
None
0.00
SAVARA INC
SOLEShares6.35M
TypeSH
Market value$9.84M
1.58%
Sole
6.35M
Shared
0.00
None
0.00
MILESTONE PHARMACEUTICALS IN
SOLEShares2.21M
TypeSH
Market value$8.75M
1.40%
Sole
2.21M
Shared
0.00
None
0.00
LIANBIO
SOLEShares4.79M
TypeSH
Market value$7.86M
1.26%
Sole
4.79M
Shared
0.00
None
0.00
MARINUS PHARMACEUTICALS INC
SOLEShares1.77M
TypeSH
Market value$7.05M
1.13%
Sole
1.77M
Shared
0.00
None
0.00
TREVI THERAPEUTICS INC
SOLEShares3.05M
TypeSH
Market value$5.89M
0.95%
Sole
3.05M
Shared
0.00
None
0.00
FULCRUM THERAPEUTICS INC
SOLEShares447.33K
TypeSH
Market value$3.26M
0.52%
Sole
447.33K
Shared
0.00
None
0.00
LYRA THERAPEUTICS INC
SOLEShares924.17K
TypeSH
Market value$2.90M
0.47%
Sole
924.17K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
VIRIDIAN THERAPEUTICS INCSOLE | COM | 2.70M | SH | $78.86M 12.66% | 2.70M | 0.00 | 0.00 |
ACLARIS THERAPEUTICS INCSOLE | COM | 4.56M | SH | $71.88M 11.54% | 4.56M | 0.00 | 0.00 |
AXSOME THERAPEUTICS INCSOLE | COM | 670.72K | SH | $51.73M 8.31% | 670.72K | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 4.04M | SH | $46.68M 7.49% | 4.04M | 0.00 | 0.00 |
TERNS PHARMACEUTICALS INCSOLE | COM | 3.71M | SH | $37.75M 6.06% | 3.71M | 0.00 | 0.00 |
GH RESEARCH PLCSOLE | ORDINARY SHARES | 3.52M | SH | $34.19M 5.49% | 3.52M | 0.00 | 0.00 |
CELCUITY INCSOLE | COM | 2.11M | SH | $29.50M 4.74% | 2.11M | 0.00 | 0.00 |
DBV TECHNOLOGIES S ASOLE | SPONSORED ADR | 9.30M | SH | $29.26M 4.70% | 9.30M | 0.00 | 0.00 |
DICE THERAPEUTICS INCSOLE | COM | 819K | SH | $25.55M 4.10% | 819K | 0.00 | 0.00 |
AEROVATE THERAPEUTICS INCSOLE | COM | 747.87K | SH | $21.91M 3.52% | 747.87K | 0.00 | 0.00 |
PLIANT THERAPEUTICS INCSOLE | COM | 1.08M | SH | $20.88M 3.35% | 1.08M | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 2.92M | SH | $19.72M 3.17% | 2.92M | 0.00 | 0.00 |
NOVAVAX INCSOLE | COM NEW | 1.88M | SH | $19.33M 3.10% | 1.88M | 0.00 | 0.00 |
MERUS N VSOLE | COM | 1.23M | SH | $18.97M 3.05% | 1.23M | 0.00 | 0.00 |
CABALETTA BIO INCSOLE | COM | 1.90M | SH | $17.53M 2.81% | 1.90M | 0.00 | 0.00 |
ANNEXON INCSOLE | COM | 3.22M | SH | $16.65M 2.67% | 3.22M | 0.00 | 0.00 |
VECTIVBIO HLDG AGSOLE | ORD SHS | 1.87M | SH | $16.17M 2.60% | 1.87M | 0.00 | 0.00 |
PROVENTION BIO INCSOLE | COM | 1.12M | SH | $11.82M 1.90% | 1.12M | 0.00 | 0.00 |
SAVARA INCSOLE | COM | 6.35M | SH | $9.84M 1.58% | 6.35M | 0.00 | 0.00 |
MILESTONE PHARMACEUTICALS INSOLE | COM | 2.21M | SH | $8.75M 1.40% | 2.21M | 0.00 | 0.00 |
LIANBIOSOLE | SPONSORED ADS | 4.79M | SH | $7.86M 1.26% | 4.79M | 0.00 | 0.00 |
MARINUS PHARMACEUTICALS INCSOLE | COM NEW | 1.77M | SH | $7.05M 1.13% | 1.77M | 0.00 | 0.00 |
TREVI THERAPEUTICS INCSOLE | COM | 3.05M | SH | $5.89M 0.95% | 3.05M | 0.00 | 0.00 |
FULCRUM THERAPEUTICS INCSOLE | COM | 447.33K | SH | $3.26M 0.52% | 447.33K | 0.00 | 0.00 |
LYRA THERAPEUTICS INCSOLE | COM | 924.17K | SH | $2.90M 0.47% | 924.17K | 0.00 | 0.00 |
Page 1 of 2